All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir And Ribavirin Delivers 100% Svr12 In Treatment-Naive Non-Cirrhotic Hcv Genotype 1 Patients With Resistance-Associated Substitutions Of A Phase 2/3 Clinical Trial In ChinaLai Wei,xiaoyuan Xu,yujuan Guan,sujun Zheng,Ji-Fang Sheng,xingxiang Yang,yuanji Ma,Yan Huang,Yi Kang,Xiaofeng Wen,Jun Li,Youwen Tan,Qing He,Qing Xie,Maorong Wang,Ping An,Guozhong Gong,Huimin Liu,Qin Ning,Rui Hua,Bo Ning,Wen Xie,Jiming Zhang,Wenxiang Huang,Yongfeng Yang,Minghua Lin,Yingren Zhao,Yanhong Yu,Ji-Dong Jia,Dongliang Yang,Liang Chen,Yinong Ye,Yuemin Nan, Zuojong Gong,Quan Zhang,Peng Hu,Fu-Sheng Wang,Yongguo Li,Dongliang Li,Zhansheng Jia,Jinlin Hou,Chengwei Chen,Jinzi WuJOURNAL OF HEPATOLOGY（2019）引用 0|浏览37暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
